Search results
Apr 2, 2024 · Roivant Sciences is a holding company that develops transformative medicines and technologies by building agile, focused companies called Vants. Learn about Roivant's model, pipeline, news, and careers.
- About Us
Roivant builds nimble subsidiaries or “Vants” to develop and...
- Pipeline
Our pipeline includes innovative product candidates across...
- Our Companies
New York. 151 W 42nd Street 15th Floor New York, NY 10036...
- For Investors
Roivant develops transformative medicines faster by building...
- Join Us
At Roivant, we employ the brightest minds from various...
- Stock Information
Today's High Today's Low 52 Week High 52 Week Low. Stock...
- Events & Presentations
Roivant 4Q and Fiscal Year 2022 Earnings Call Presentation...
- Press Releases
Roivant to Report Financial Results for the Fourth Quarter...
- About Us
Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy
Roivant develops and commercializes medicines and technologies by creating focused companies called Vants. Learn about their pipeline, launch, culture, and vision.
Find the latest Roivant Sciences Ltd. (ROIV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Roivant is a biopharmaceutical company with a broad and differentiated pipeline of product candidates across immunology, oncology, hematology, and dermatology. It has run 10 positive Phase 3 trials since 2019 and has a nimble, entrepreneurial model of Vants.
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and...
Roivant is a biopharmaceutical company that develops and launches Vants, or nimble and focused biotech companies. Find stock information, press releases, and business updates on its investor relations website.
